THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN
401k plan membership statisitcs for THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN
Measure | Date | Value |
---|
2023: THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2023 401k membership |
---|
Total participants, beginning-of-year | 2023-01-01 | 3 |
Total number of active participants reported on line 7a of the Form 5500 | 2023-01-01 | 4 |
Number of retired or separated participants receiving benefits | 2023-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2023-01-01 | 0 |
Total of all active and inactive participants | 2023-01-01 | 4 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2023-01-01 | 0 |
Total participants | 2023-01-01 | 4 |
Number of participants with account balances | 2023-01-01 | 3 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2023-01-01 | 0 |
2022: THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2022 401k membership |
---|
Total participants, beginning-of-year | 2022-01-01 | 3 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 3 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 0 |
Total of all active and inactive participants | 2022-01-01 | 3 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 0 |
Total participants | 2022-01-01 | 3 |
Number of participants with account balances | 2022-01-01 | 3 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 0 |
2021: THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2021 401k membership |
---|
Total participants, beginning-of-year | 2021-01-01 | 3 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 3 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 0 |
Total of all active and inactive participants | 2021-01-01 | 3 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 0 |
Total participants | 2021-01-01 | 3 |
Number of participants with account balances | 2021-01-01 | 3 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
2020: THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2020 401k membership |
---|
Total participants, beginning-of-year | 2020-01-01 | 3 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 3 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 0 |
Total of all active and inactive participants | 2020-01-01 | 3 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 0 |
Total participants | 2020-01-01 | 3 |
Number of participants with account balances | 2020-01-01 | 3 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 0 |
2019: THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2019 401k membership |
---|
Total participants, beginning-of-year | 2019-01-01 | 2 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 3 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 0 |
Total of all active and inactive participants | 2019-01-01 | 3 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 0 |
Total participants | 2019-01-01 | 3 |
Number of participants with account balances | 2019-01-01 | 2 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 0 |
Measure | Date | Value |
---|
2023 : THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2023 401k financial data |
---|
Transfers to/from the plan | 2023-12-31 | $0 |
Total plan liabilities at end of year | 2023-12-31 | $0 |
Total plan liabilities at beginning of year | 2023-12-31 | $0 |
Total income from all sources | 2023-12-31 | $155,492 |
Expenses. Total of all expenses incurred | 2023-12-31 | $200 |
Benefits paid (including direct rollovers) | 2023-12-31 | $0 |
Total plan assets at end of year | 2023-12-31 | $3,535,128 |
Total plan assets at beginning of year | 2023-12-31 | $3,379,836 |
Value of fidelity bond covering the plan | 2023-12-31 | $400,000 |
Total contributions received or receivable from participants | 2023-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2023-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2023-12-31 | $0 |
Other income received | 2023-12-31 | $147,163 |
Noncash contributions received | 2023-12-31 | $0 |
Net income (gross income less expenses) | 2023-12-31 | $155,292 |
Net plan assets at end of year (total assets less liabilities) | 2023-12-31 | $3,535,128 |
Net plan assets at beginning of year (total assets less liabilities) | 2023-12-31 | $3,379,836 |
Total contributions received or receivable from employer(s) | 2023-12-31 | $8,329 |
Value of certain deemed distributions of participant loans | 2023-12-31 | $0 |
Value of corrective distributions | 2023-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2023-12-31 | $200 |
2022 : THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2022 401k financial data |
---|
Transfers to/from the plan | 2022-12-31 | $0 |
Total plan liabilities at end of year | 2022-12-31 | $0 |
Total plan liabilities at beginning of year | 2022-12-31 | $0 |
Total income from all sources | 2022-12-31 | $-128,232 |
Expenses. Total of all expenses incurred | 2022-12-31 | $8,839 |
Benefits paid (including direct rollovers) | 2022-12-31 | $8,614 |
Total plan assets at end of year | 2022-12-31 | $3,379,836 |
Total plan assets at beginning of year | 2022-12-31 | $3,516,907 |
Value of fidelity bond covering the plan | 2022-12-31 | $290,000 |
Assets. Value of tangible personal property | 2022-12-31 | $0 |
Total contributions received or receivable from participants | 2022-12-31 | $0 |
Assets. Value of loans (other than to participants) | 2022-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2022-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2022-12-31 | $0 |
Other income received | 2022-12-31 | $-135,798 |
Noncash contributions received | 2022-12-31 | $0 |
Net income (gross income less expenses) | 2022-12-31 | $-137,071 |
Net plan assets at end of year (total assets less liabilities) | 2022-12-31 | $3,379,836 |
Net plan assets at beginning of year (total assets less liabilities) | 2022-12-31 | $3,516,907 |
Assets. Value of participant loans | 2022-12-31 | $0 |
Assets. Value of assets in partnership/joint-venture interests | 2022-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2022-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2022-12-31 | $0 |
Assets. Value of employer securities | 2022-12-31 | $0 |
Assets. Value of employer real property | 2022-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2022-12-31 | $7,566 |
Value of certain deemed distributions of participant loans | 2022-12-31 | $0 |
Value of corrective distributions | 2022-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2022-12-31 | $225 |
2021 : THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2021 401k financial data |
---|
Transfers to/from the plan | 2021-12-31 | $0 |
Total plan liabilities at end of year | 2021-12-31 | $0 |
Total plan liabilities at beginning of year | 2021-12-31 | $0 |
Total income from all sources | 2021-12-31 | $156,057 |
Expenses. Total of all expenses incurred | 2021-12-31 | $200 |
Benefits paid (including direct rollovers) | 2021-12-31 | $0 |
Total plan assets at end of year | 2021-12-31 | $3,516,907 |
Total plan assets at beginning of year | 2021-12-31 | $3,361,050 |
Value of fidelity bond covering the plan | 2021-12-31 | $290,000 |
Assets. Value of tangible personal property | 2021-12-31 | $0 |
Total contributions received or receivable from participants | 2021-12-31 | $0 |
Assets. Value of loans (other than to participants) | 2021-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2021-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2021-12-31 | $0 |
Other income received | 2021-12-31 | $156,057 |
Noncash contributions received | 2021-12-31 | $0 |
Net income (gross income less expenses) | 2021-12-31 | $155,857 |
Net plan assets at end of year (total assets less liabilities) | 2021-12-31 | $3,516,907 |
Net plan assets at beginning of year (total assets less liabilities) | 2021-12-31 | $3,361,050 |
Assets. Value of participant loans | 2021-12-31 | $0 |
Assets. Value of assets in partnership/joint-venture interests | 2021-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2021-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2021-12-31 | $0 |
Assets. Value of employer securities | 2021-12-31 | $0 |
Assets. Value of employer real property | 2021-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2021-12-31 | $0 |
Value of certain deemed distributions of participant loans | 2021-12-31 | $0 |
Value of corrective distributions | 2021-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2021-12-31 | $200 |
2020 : THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2020 401k financial data |
---|
Transfers to/from the plan | 2020-12-31 | $0 |
Total plan liabilities at end of year | 2020-12-31 | $0 |
Total plan liabilities at beginning of year | 2020-12-31 | $0 |
Total income from all sources | 2020-12-31 | $380,329 |
Expenses. Total of all expenses incurred | 2020-12-31 | $200 |
Benefits paid (including direct rollovers) | 2020-12-31 | $0 |
Total plan assets at end of year | 2020-12-31 | $3,361,050 |
Total plan assets at beginning of year | 2020-12-31 | $2,980,921 |
Value of fidelity bond covering the plan | 2020-12-31 | $290,000 |
Assets. Value of tangible personal property | 2020-12-31 | $0 |
Total contributions received or receivable from participants | 2020-12-31 | $0 |
Assets. Value of loans (other than to participants) | 2020-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2020-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2020-12-31 | $0 |
Other income received | 2020-12-31 | $369,497 |
Noncash contributions received | 2020-12-31 | $0 |
Net income (gross income less expenses) | 2020-12-31 | $380,129 |
Net plan assets at end of year (total assets less liabilities) | 2020-12-31 | $3,361,050 |
Net plan assets at beginning of year (total assets less liabilities) | 2020-12-31 | $2,980,921 |
Assets. Value of participant loans | 2020-12-31 | $0 |
Assets. Value of assets in partnership/joint-venture interests | 2020-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2020-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2020-12-31 | $0 |
Assets. Value of employer securities | 2020-12-31 | $0 |
Assets. Value of employer real property | 2020-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2020-12-31 | $10,832 |
Value of certain deemed distributions of participant loans | 2020-12-31 | $0 |
Value of corrective distributions | 2020-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2020-12-31 | $200 |
2019 : THE NEUROLOGY & HEADACHE CENTER OF N.J., LLC MARK LAZAR, M.D. PROFIT SHARING PLAN 2019 401k financial data |
---|
Transfers to/from the plan | 2019-12-31 | $1,338,044 |
Total plan liabilities at end of year | 2019-12-31 | $0 |
Total plan liabilities at beginning of year | 2019-12-31 | $0 |
Total income from all sources | 2019-12-31 | $405,736 |
Expenses. Total of all expenses incurred | 2019-12-31 | $138 |
Benefits paid (including direct rollovers) | 2019-12-31 | $0 |
Total plan assets at end of year | 2019-12-31 | $2,980,921 |
Total plan assets at beginning of year | 2019-12-31 | $1,237,279 |
Value of fidelity bond covering the plan | 2019-12-31 | $290,000 |
Total contributions received or receivable from participants | 2019-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2019-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2019-12-31 | $0 |
Other income received | 2019-12-31 | $286,193 |
Noncash contributions received | 2019-12-31 | $0 |
Net income (gross income less expenses) | 2019-12-31 | $405,598 |
Net plan assets at end of year (total assets less liabilities) | 2019-12-31 | $2,980,921 |
Net plan assets at beginning of year (total assets less liabilities) | 2019-12-31 | $1,237,279 |
Total contributions received or receivable from employer(s) | 2019-12-31 | $119,543 |
Value of certain deemed distributions of participant loans | 2019-12-31 | $0 |
Value of corrective distributions | 2019-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2019-12-31 | $138 |